A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents

IMPORTANCE: Few studies have compared the use of methotrexate and biologics, the most commonly used systemic medications for treatment of moderate to severe psoriasis in children. OBJECTIVE: To assess the real-world, 6-month reduction in psoriasis severity and long-term drug survival (rate and durat...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Dermatol
Главные авторы: Bronckers, Inge M. G. J., Paller, Amy S., West, Dennis P., Lara-Corrales, Irene, Tollefson, Megha M., Tom, Wynnis L., Hogeling, Marcia, Belazarian, Leah, Zachariae, Claus, Mahé, Emmanuel, Siegfried, Elaine, Blume-Peytavi, Ulrike, Szalai, Zsuzsanna, Vleugels, Ruth Ann, Holland, Kristen, Murphy, Ruth, Puig, Lluís, Cordoro, Kelly M., Lambert, Jo, Alexopoulos, Alex, Mrowietz, Ulrich, Kievit, Wietske, Seyger, Marieke M. B.
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2020
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042803/
https://ncbi.nlm.nih.gov/pubmed/32022846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2019.4835
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы